Amneal Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
11 Aug 23 | SellUS$120,921 | Andrew Boyer | Individual | 29,302 | US$4.13 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 0 | 0% |
Private Companies | 9,235,037 | 2.99% |
General Public | 47,448,937 | 15.4% |
Institutions | 88,925,834 | 28.8% |
Individual Insiders | 162,944,420 | 52.8% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
53,578,209 | US$324.1m | 0% | no data | |||
30,384,769 | US$183.8m | 0% | no data | |||
26,905,073 | US$162.8m | 0% | no data | |||
25,265,818 | US$152.9m | 0% | no data | |||
21,781,986 | US$131.8m | 0% | no data | |||
13,642,387 | US$82.5m | 0.69% | no data | |||
12,328,767 | US$74.6m | 0% | 0.24% | |||
9,200,603 | US$55.7m | -57.3% | no data | |||
8,846,421 | US$53.5m | 10.1% | no data | |||
8,000,000 | US$48.4m | 98.8% | 1.53% | |||
6,497,090 | US$39.3m | 142% | 0.04% | |||
3,741,007 | US$22.6m | -2.21% | 0.02% | |||
2,822,613 | US$17.1m | 42.9% | no data | |||
2,799,057 | US$16.9m | 19.9% | no data | |||
2,439,247 | US$14.8m | 5.13% | no data | |||
2,334,397 | US$14.1m | 5.5% | 1.36% | |||
1,955,290 | US$11.8m | 5.71% | no data | |||
1,931,386 | US$11.7m | -93.7% | no data | |||
1,407,157 | US$8.5m | 260% | no data | |||
1,329,508 | US$8.0m | 0% | no data | |||
1,320,635 | US$8.0m | 9.44% | no data | |||
1,089,300 | US$6.6m | -23.8% | 0.01% | |||
828,580 | US$5.0m | -11.8% | 0.01% | |||
811,676 | US$4.9m | -21.1% | 0.01% | |||
785,834 | US$4.8m | 29.5% | 0.01% |